No abstract available
MeSH terms
-
Adolescent
-
Antineoplastic Agents / therapeutic use
-
Biopsy
-
Bone Marrow / pathology
-
Chromosomal Proteins, Non-Histone / genetics*
-
Chromosome Banding
-
Dasatinib / therapeutic use*
-
Humans
-
Immunohistochemistry
-
Leukemia, Myeloid, Acute / diagnosis
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / genetics*
-
Male
-
Nuclear Pore Complex Proteins / genetics*
-
Nuclear Proteins / genetics*
-
Oncogene Proteins / genetics*
-
Oncogene Proteins, Fusion / genetics*
-
Poly-ADP-Ribose Binding Proteins / genetics*
-
Protein Kinase Inhibitors / therapeutic use
-
Receptor, Platelet-Derived Growth Factor beta / genetics*
-
Receptors, Cytoplasmic and Nuclear / genetics*
-
Repressor Proteins / genetics*
-
Translocation, Genetic
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Chromosomal Proteins, Non-Histone
-
DEK protein, human
-
NUP214 protein, human
-
Nuclear Pore Complex Proteins
-
Nuclear Proteins
-
Oncogene Proteins
-
Oncogene Proteins, Fusion
-
Poly-ADP-Ribose Binding Proteins
-
Protein Kinase Inhibitors
-
Receptors, Cytoplasmic and Nuclear
-
Repressor Proteins
-
TBL1XR1 protein, human
-
PDGFRB protein, human
-
Receptor, Platelet-Derived Growth Factor beta
-
Dasatinib